Windtree Therapeutics Inc... (WINT)
NASDAQ: WINT
· Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:57 PM
0.51
-1.07%
After-hours: Aug 15, 2025, 07:58 PM EDT
Windtree Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.04M | 2.77M | -2.75M | -12.02M | 10.22M | -5.15M | -4.42M | -6.6M | -4.11M | -9.69M | -4.06M | -17.33M | -8.13M | -13.07M | -8.21M | -37.39M | -8.96M |
Depreciation & Amortization | 17K | -293K | 127K | 229K | 21K | 22K | 110K | 236K | 23K | 24K | 21K | 22K | 466K | 52K | 47K | 48K | 45K |
Stock-Based Compensation | 72K | 21K | 86K | 97K | 251K | 306K | 305K | 382K | 285K | 791K | 744K | 781K | 770K | 1.62M | 1.63M | 1.54M | 2.44M |
Other Working Capital | 260K | 984K | -1.42M | 428K | 310K | 1.04M | 340K | -77K | 159K | -671K | -254K | -615K | 207K | 524K | 762K | -968K | 92K |
Other Non-Cash Items | 58K | -6.99M | -1.57M | 7.66M | -14.63M | 358K | -164K | 2.35M | 621K | 7.7M | 108K | 11.54M | -62K | 7.49M | 169K | 166K | 664K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.37M | n/a | n/a | n/a | -1.66M | 31K | 29.85M | -109K |
Change in Working Capital | 1.49M | 809K | -2.34M | 1.71M | 1.19M | 901K | 320K | 134K | 663K | -832K | -916K | -267K | 238K | 635K | 1.06M | -1.62M | -130K |
Operating Cash Flow | -2.41M | -3.69M | -6.44M | -2.33M | -2.95M | -3.57M | -3.85M | -3.5M | -2.52M | -3.38M | -4.1M | -5.26M | -6.71M | -4.93M | -5.28M | -7.4M | -6.05M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10K | -3K | -173K | -103K | -3K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210.00 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -15K | n/a | n/a | n/a | n/a | 200K | -3K | -173K | -103K | -3K | n/a |
Debt Repayment | 84K | 89K | -261K | 1.66M | -233K | -234K | -233K | -78K | -252K | n/a | n/a | n/a | -294K | n/a | -440K | -2.64M | -352K |
Common Stock Repurchased | -483K | -1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -90K | -310K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.29M | 8.59M | -1.09M | -68K | -100K | n/a | n/a | n/a | 843K | -377K | -378K | -125K | 205K | -241K | 400K | 400K | n/a |
Financial Cash Flow | 1.8M | 3.16M | 6.94M | 1.59M | 1.03M | 521K | -233K | 10.72M | 591K | 1.12M | 1.16M | 895K | -89K | 2.91M | -40K | -1.12M | 27.61M |
Net Cash Flow | -606K | -521K | 497K | -744K | -1.91M | -3.05M | -4.1M | 7.22M | -1.93M | -2.26M | -2.94M | -4.16M | -6.81M | -2.19M | -5.42M | -8.53M | 21.56M |
Free Cash Flow | -2.41M | -3.69M | -6.44M | -2.34M | -2.95M | -3.57M | -3.87M | -3.5M | -2.52M | -3.38M | -4.1M | -5.27M | -6.72M | -5.11M | -5.38M | -7.41M | -6.05M |